pharmaceutical investing AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena
pharmaceutical investing AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
pharmaceutical investing AMAG Pharmaceuticals Submits a New Drug Application to the U.S. Food and Drug Administration
pharmaceutical investing AMAG Pharmaceuticals Announces FDA Approval of Supplemental New Drug Application for Feraheme
pharmaceutical investing AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa™ (Prasterone)
pharmaceutical investing AMAG Pharmaceuticals Announces Closing of Exclusive Licensing Agreement for North American Rights to Rekynda™
AMAG Pharmaceuticals Announces Achievement of Key Milestones in Next Generation Development Programs for Makena® and Feraheme®
Stallion Uranium to Resume Trading on the TSX-V and Enters into Agreement to Sell Shares of 1503571 B.C. LTD.
BTV Highlights: North American Iron, West Red Lake Gold Mines, Northisle Copper and Gold, Westport Fuels, US Gold, Orvana Minerals, Avino Silver & Gold, Pasofino Gold, & Mayfair Gold
